3
Announcements
Trials
Browse
Landscape
Status
Completed
72
Recruiting
26
Active not recruiting
18
Terminated
15
Unknown
7
Approved for marketing
2
Withdrawn
1
Not yet recruiting
1
No longer available
1
Enrolling by invitation
1
Sponsor Class
OTHER
3
INDUSTRY
1
Study Type
Expanded_access
1
Sponsor
Cancer Type
Thoracic
20
Gastrointestinal
19
Dermatologic
18
Other hematologic neoplasm
17
Plasma cell
16
Lymphoid
15
CNS
14
Genitourinary
11
Sarcoma
10
Breast
10
Other solid neoplasm
7
Tumor-Agnostic
6
Myeloid
6
Gynecologic
3
Head & Neck
2
NET
1
Endocrine
1
Conditions
Neuroendocrine Tumors
1
Interventions
surufatinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
No longer available
×
INDUSTRY
×
NET
×
Clear all
NCT04814732
2024-04-12
Expanded Access Program of Surufatinib
Hutchmed
No longer available